½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹MN1¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹MN1¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW19108
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º  Íÿ¹MN1¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£º  Anti-MN1 rabbit polyclonal antibody


±ð      Ãû£º  MGCR; MGCR1; MGCR1-PEN; dJ353E16.2

Ïà¹ØÀà±ð£º  Ò»¿¹


´¢     ´æ£º  Àä¶³£¨-20¡æ£© ±Ü¹â


¿¹     Ô­£º  MN1


ËÞ     Ö÷£º  Rabbit


·´Ó¦ÖÖÊô£º  Human


±ê ¼Ç Î  Unconjugate


¿Ë¡ÀàÐÍ£º  Unconjugate


¼¼Êõ¹æ¸ñ

Background:

Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. May play a role in tumor suppression.

Applications:

WB

Name of antibody:

MN1

Immunogen:

Synthesized peptide derived from internal of human MN1.

Full name:

meningioma (disrupted in balanced translocation) 1

Synonyms£º

MGCR; MGCR1; MGCR1-PEN; dJ353E16.2

SwissProt:

Q10571

WB Predicted band size:

136 kDa

WB Positive control:

COLO cells lysate

WB Recommended dilution:

500-3000




¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿